全文获取类型
收费全文 | 115391篇 |
免费 | 8349篇 |
国内免费 | 4153篇 |
专业分类
耳鼻咽喉 | 316篇 |
儿科学 | 2667篇 |
妇产科学 | 1188篇 |
基础医学 | 10969篇 |
口腔科学 | 865篇 |
临床医学 | 17826篇 |
内科学 | 16673篇 |
皮肤病学 | 486篇 |
神经病学 | 10689篇 |
特种医学 | 4956篇 |
外国民族医学 | 8篇 |
外科学 | 7851篇 |
综合类 | 22593篇 |
现状与发展 | 6篇 |
预防医学 | 6182篇 |
眼科学 | 975篇 |
药学 | 11310篇 |
130篇 | |
中国医学 | 9906篇 |
肿瘤学 | 2297篇 |
出版年
2024年 | 104篇 |
2023年 | 1414篇 |
2022年 | 1913篇 |
2021年 | 3810篇 |
2020年 | 3941篇 |
2019年 | 3252篇 |
2018年 | 3234篇 |
2017年 | 3605篇 |
2016年 | 3769篇 |
2015年 | 3839篇 |
2014年 | 7004篇 |
2013年 | 7320篇 |
2012年 | 6487篇 |
2011年 | 6893篇 |
2010年 | 5593篇 |
2009年 | 5094篇 |
2008年 | 5296篇 |
2007年 | 5557篇 |
2006年 | 5125篇 |
2005年 | 4743篇 |
2004年 | 4219篇 |
2003年 | 3928篇 |
2002年 | 3451篇 |
2001年 | 3191篇 |
2000年 | 2696篇 |
1999年 | 2316篇 |
1998年 | 1934篇 |
1997年 | 1963篇 |
1996年 | 1614篇 |
1995年 | 1671篇 |
1994年 | 1546篇 |
1993年 | 1187篇 |
1992年 | 1135篇 |
1991年 | 1023篇 |
1990年 | 803篇 |
1989年 | 775篇 |
1988年 | 716篇 |
1987年 | 595篇 |
1986年 | 552篇 |
1985年 | 814篇 |
1984年 | 659篇 |
1983年 | 430篇 |
1982年 | 566篇 |
1981年 | 479篇 |
1980年 | 371篇 |
1979年 | 271篇 |
1978年 | 226篇 |
1977年 | 202篇 |
1976年 | 184篇 |
1975年 | 85篇 |
排序方式: 共有10000条查询结果,搜索用时 28 毫秒
81.
82.
83.
84.
85.
86.
87.
Hildegunn Norbakken Granslo Elizabeth G. Aarag Fredheim Eirin Esaiassen Lars Christophersen Peter
strup Jensen Tom Eirik Mollnes Claus Moser Trond Flgstad Claus Klingenberg Jorunn Pauline Cavanagh 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2019,127(6):475-483
The global spread of antimicrobial resistance and the increasing number of immune‐compromised patients are major challenges in modern medicine. Targeting bacterial virulence or the human host immune system to increase host defence are important strategies in the search for novel antimicrobial drugs. We investigated the inflammatory response of the synthetic short antimicrobial peptide LTX21 in two model systems: a human whole blood ex vivo model and a murine in vivo peritoneum model – both reflecting early innate immune response. In the whole blood model, LTX21 increased the secretion of a range of different cytokines, decreased the level of tumour necrosis factor (TNF) and activated the complement system. In a haemolysis assay, we found 2.5% haemolysis at a LTX21 concentration of 500 mg/L. In the murine model, increased influx of white blood cells (WBCs) and polymorphonuclear neutrophils (PMNs) in the murine peritoneal cavity was observed after treatment with LTX21. In addition, LTX21 increased monocyte chemoattractant protein‐1 (MCP‐1). In conclusion, LTX21 affected the inflammatory response; the increase in cytokine secretion, complement activation and WBC influx indicates an activated inflammatory response. The present results indicate the impact of LTX21 on the host–pathogen interplay. Whether this will also affect the course of infection has to be investigated. 相似文献
88.
89.
Background
Aneurysmal subarachnoid hemorrhage is an important cause of premature death and disability worldwide. Magnesium sulphate is shown to have a neuroprotective effect and it reverses cerebral vasospasm. Milrinone is also used in the treatment of cerebral vasospasm. The aim of the present study was to compare the effect of prophylactic magnesium sulphate and milrinone on the incidence of cerebral vasospasm after subarachnoid hemorrhage.Methods
The study included 90 patients with aneurysmal subarachnoid hemorrhage classified randomly (by simple randomization) into two groups: magnesium sulphate was given as an infusion of 500 mg.day?1 without loading dose for 21 days. Group B: milrinone was given as an infusion of 0.5 μg.kg?1.min?1 without loading dose for 21 days. The cerebral vasospasm was diagnosed by mean cerebral blood flow velocity in the involved cerebral artery (mean flow velocity ≥ 120 cm.s?1), neurological deterioration by Glasgow coma scale, or angiography (the decrease in diameter of the involved cerebral artery >25%).Results
The mean cerebral blood flow velocity decreased significantly in the magnesium group compared to milrinone group through Day 7, Day 14 and Day 21 (p < 0.001). The incidence of cerebral vasospasm decreased significantly with magnesium compared to milrinone (p = 0.007). The Glasgow coma scale significantly improved in the magnesium group compared to milrinone group through Day 7, Day 14 and Day 21 (p = 0.036, p = 0.012, p = 0.016, respectively). The incidence of hypotension was higher with milrinone than magnesium (p = 0.012).Conclusions
The incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage was significantly lower and Glasgow coma scale significantly better with magnesium when compared to milrinone. Milrinone was associated with a higher incidence of hypotension and requirement for dopamine and norepinephrine when compared to magnesium. 相似文献90.